Lung Cancer Foundation of America logo
Donate
  • About Us
    • Board of Directors
    • Scientific Advisory Board
    • Newsroom
    • Speakers Bureau
    • Community Outreach
    • Sponsors
    • Contact Us
    • Legal
  • About Lung Cancer
    • Detection
    • Diagnosis
    • Treatments
    • Lung Cancer Facts
    • Lung Cancer Resources
  • Research
    • Latest Research
    • Clinical Trials
    • Grant Opportunities
    • Grant Recipients
    • Meet the Investigators
  • Living with Lung Cancer
    • The First 7 Days Podcast
    • Survivor Stories
    • Tributes
    • Hope With Answers℠ Videos
    • Hope With Answers℠ Podcast
  • Get Involved
    • Lung Cancer Awareness Month
    • Join Us
    • Contribute
    • Events
    • Advocacy
  • Hope
  • Research
  • Life
  • About Us
    • Board of Directors
    • Scientific Advisory Board
    • Newsroom
    • Speakers Bureau
    • Community Outreach
    • Sponsors
    • Contact Us
    • Legal
  • About Lung Cancer
    • Detection
    • Diagnosis
    • Treatments
    • Lung Cancer Facts
    • Lung Cancer Resources
  • Research
    • Latest Research
    • Clinical Trials
    • Grant Opportunities
    • Grant Recipients
    • Meet the Investigators
  • Living with Lung Cancer
    • The First 7 Days Podcast
    • Survivor Stories
    • Tributes
    • Hope With Answers℠ Videos
    • Hope With Answers℠ Podcast
  • Get Involved
    • Lung Cancer Awareness Month
    • Join Us
    • Contribute
    • Events
    • Advocacy
  • Donate
  • Hope
  • Research
  • Life

What Can We Help You Find?

Category: Tributes

A Commitment to Advocacy: Don Stranathan’s Story

LCFA is saddened by the loss of Donald Stranathan, who passed away on Saturday, February 1, 2020, after 10+ years as a lung cancer patient and advocate. Don will always be known for his commitment to advocating for lung...
Read More
|
Tributes

From coughing up blood to adenocarcinoma: Elizabeth Moir’s Story

LCFA is saddened by the loss of Elizabeth Moir, who passed away on Friday, August 27, 2021 at the age of 32. A mother of 2 beautiful girls under the age of 5, a wife, a daughter, a friend,...
Read More
|
Tributes

Unbreakable: Gina Hollenbeck’s Fight Against ALK Positive Lung Cancer

Sadly, LCFA Speaker and lung cancer patient/advocate Gina Hollenbeck passed away on June 12, 2022. Gina's guiding principle comes from a phrase in a book she read by Dale Carnegie in which he wrote: "Two men looked out from...
Read More
|
Tributes

Spreading Love and Coping with Lung Cancer: Lisa James’s Story

LCFA is saddened by the loss of Lisa James who passed away in 2020. When she was diagnosed, at age 47, she had just started a fabulous new life with her new husband, Preston. When she was diagnosed with...
Read More
|
Tributes

Millie Torchia’s Fight Against Lung Cancer

At LCFA we are honored to share the stories of lung cancer patients who are not only fighting for their lives, but managing to find the time, strength, and drive to advocate for more and better lung cancer research. ...
Read More
|
Tributes

Storyteller, Family, and Lung Cancer: Julie Levinson

I am the writer behind many of the survivor stories on this website. It has been my privilege to interview lung cancer patients and survivors, each with their own remarkable story. For most, their diagnosis came as a shock....
Read More
|
Tributes

(A father + a daughter) + a truck = lung cancer awareness

When April DeFalco Rempfer’s father Bill developed a nagging pain in his shoulder, he – and his primary care physician – chalked it up to an occupational hazard. As a former police officer and longtime owner/operator of a major...
Read More
|
Tributes

A Mother’s Day Gift: When The Patient Becomes the Healer

Laronica Conway's mother Lillie loved biology, science projects, and working with kids. Growing up in tiny Independence, Louisiana, education was a top priority in her family. As a child, Lillie dreamed of becoming a pediatrician. But she knew that...
Read More
|
Tributes

Exercising after chemotherapy: When a weightlifter gets an unexpected diagnosis

LCFA is saddened by the loss of Dave Miller, who passed away on Tuesday, January 11, 2019, at the age of 50. Dave will always be known for his positive attitude and his great sense of humor. We were...
Read More
|
Tributes

Heroes

Read More
|
Tributes

Or Search Our Site By Topic:

Advocacy advocacy ALK+ awareness biomarker biomarker testing chemotherapy clinical trial Clinical Trials clinical trials combination therapy Detection Diagnosis diagnosis early detection education EGFR EGFR mutation Fundraising genomic testing immunotherapy Immunotherapy KRAS latest research Living with Lung Cancer Lung Cancer Info lung cancer research non-smoker NSCLC patient support personalized medicine radiation Research ROS1 SCLC small cell lung cancer speakers bureau stage 4 Survivors Targeted therapy targeted therapy Treatment treatment Tributes Uncategorized

More

  • About Us
    • Board of Directors
    • Scientific Advisory Board
    • Newsroom
    • Speakers Bureau
    • Community Outreach
    • Sponsors
    • Contact Us
    • Legal
  • About Lung Cancer
    • Detection
    • Diagnosis
    • Treatments
    • Lung Cancer Facts
    • Lung Cancer Resources
  • Research
    • Latest Research
    • Clinical Trials
    • Grant Opportunities
    • Grant Recipients
    • Meet the Investigators
  • Living with Lung Cancer
    • The First 7 Days Podcast
    • Survivor Stories
    • Tributes
    • Hope With Answers℠ Videos
    • Hope With Answers℠ Podcast
  • Get Involved
    • Lung Cancer Awareness Month
    • Join Us
    • Contribute
    • Events
    • Advocacy

Give with Confidence


      

Our Mission

LCFA’s mission is the improvement in survivorship of lung cancer patients through the funding of transformative science.

While raising funds to support lung cancer research, LCFA will raise the public’s awareness and serve as a resource for patients or anyone seeking answers, hope, and access to updated treatment information, scientific investigation, and clinical trials.



Latest In Research

03/9
2023

Keytruda Meets Trial Goals for Non-Small Cell Lung Cancer Treatment

In the phase 3 KEYNOTE-671 trial evaluating Keytruda (pembrolizumab) as preoperative treatment (a regimen given before and after surgier) in patients with resectable stage 2, 3a or 3b non-small cell lung cancer has met one of its primary e…

Sign up

Get the latest news about lung cancer research.

Connect with us



©2023 Lung Cancer Foundation of America. All Rights Reserved. EIN 20-8730839

Sponsors    |    Legal and Privacy    |    Media Contact    |   State Fundraising Notices